Pharma steps up as coronavirus cases soar to 400,000-plusWith the coronavirus pandemic gathering momentum outside China, AstraZeneca has said it will donate 9 million face masks Share XPharma steps up as coronavirus cases soar to 400,000-plushttps://pharmaphorum.com/news/pharma-steps-up-as-coronavirus-cases-soar-to-400000-plus/
Trump pledges access to malaria drug chloroquine for COVID-19President Donald Trump thrust a decades old malaria drug called chloroquine into the forefront of efforts to treat Share XTrump pledges access to malaria drug chloroquine for COVID-19https://pharmaphorum.com/news/trump-pledges-access-to-malaria-drug-chloroquine-for-covid-19/
UK’s tougher COVID-19 guidance not enough, say scientistsResearchers at Imperial College London say that up to 250,000 people could die in the UK as a Share XUK’s tougher COVID-19 guidance not enough, say scientistshttps://pharmaphorum.com/news/uks-tougher-covid-19-guidance-not-enough-say-scientists/
Stem cell transplant eradicates HIV in second patientA second man with HIV has been cured of the infection after receiving a transplant of stem cells Share XStem cell transplant eradicates HIV in second patienthttps://pharmaphorum.com/news/stem-cell-transplant-eradicates-hiv-in-second-patient/
FDA clears emergency diagnostic as coronavirus fears mountThe US drugs regulator has approved emergency use of a diagnostic for the strain of coronavirus causing the Share XFDA clears emergency diagnostic as coronavirus fears mounthttps://pharmaphorum.com/news/fda-clears-emergency-diagnostic-as-coronavirus-fears-mount/
ViiV’s two-drug HIV therapy Dovato gets Japanese approvalOne of ViiV Healthcare’s two-drug HIV therapies – Dovato – has been approved in Japan, providing a new Share XViiV’s two-drug HIV therapy Dovato gets Japanese approvalhttps://pharmaphorum.com/news/viivs-two-drug-hiv-therapy-dovato-gets-japanese-approval/
ViiV files first-in-class HIV drug in EuropeViiV Healthcare has filed its new HIV drug fostemsavir for approval in Europe, a few weeks after the Share XViiV files first-in-class HIV drug in Europehttps://pharmaphorum.com/news/viiv-files-first-in-class-hiv-drug-in-europe/
FDA knocks back ViiV, J&J’s long-acting HIV regimenPeople with HIV hoping to be freed from daily doses of tablets will have to wait a little Share XFDA knocks back ViiV, J&J’s long-acting HIV regimenhttps://pharmaphorum.com/news/fda-knocks-back-viiv-jjs-long-acting-hiv-regimen/
ViiV presses go on FDA filing for first-in-class HIV drug fostemsavirViiV Healthcare has fulfilled its pledge of submitting its new HIV drug fostemsavir for approval before year end, Share XViiV presses go on FDA filing for first-in-class HIV drug fostemsavirhttps://pharmaphorum.com/news/viiv-presses-go-on-fda-filing-for-first-in-class-hiv-drug-fostemsavir/
